1. Lymph node ratio is a reliable prognostic marker after neoadjuvant therapy and pancreaticoduodenectomy for pancreatic cancer, but does not predict the utility of adjuvant therapy. (2021) Authors: Adams, A.; McCarthy, P.; O'Shea, A.; Bader, J.; Clifton, G.; Peoples, G.; Nelson, D.; Vreeland, T. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S605 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lymph Node Ratio Is a Reliable Prognostic Marker after Neoadjuvant Therapy and Pancreaticoduodenectomy for Pancreatic Cancer, but Does Not Predict the Utility of Adjuvant Therapy. (2022) Authors: Adams, A.; Carpenter, E.; Valdera, F.; O'Shea, A.; McCarthy, P.; Bader, J.; Clifton, G.; Peoples, G.; Nelson, D.; Vreeland, T. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. National trends in the management of small localized non-functioning pancreatic neuroendocrine tumors. (2021) Authors: Ellis, O.; Kemp Bohan, P.; Bader, J.; Vreeland, T.; Nelson, D.W. Journal: HPB Issue: Volume 23(2021)Supplement 2 Page Start: S613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. National Trends in the Management of Small Localized Non-Functioning Pancreatic Neuroendocrine Tumors. (2022) Authors: Ellis, O.; Bohan, P. Kemp; Bader, J.; Vreeland, T.; Nelson, D. Journal: HPB Issue: Volume 24(2022)Supplement 1 Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗